InvestorsHub Logo
Followers 14
Posts 820
Boards Moderated 0
Alias Born 07/03/2019

Re: stockweiser post# 16551

Thursday, 04/09/2020 9:05:14 AM

Thursday, April 09, 2020 9:05:14 AM

Post# of 16750
Agree, after all they are replicating the subgroup of their earlier trial.

As far as the management team: there doesn't seem to be a lot of trust developed by them towards the 'Street'.

I see two ways to play this... sell into the pop...

Hold for long term...who buys it, or do they transition to a sales team...

Thot of previous trial, they found after it was complete, and a fail that the dosing for 40 minutes was the key.

How did they not indicate a length of dose in the trial protocol?

That is a severely damaging oversight...

I have no medical training, and good thing for the rest of the world.